News & Insights
Poster: Enhancing Cardiometabolic Disease Research through AccessCMD

A Novel Approach to Patient Recruitment and Data Collection

The burden of cardiometabolic diseases (CMD) such as diabetes, heart disease, and stroke, along with associated risk factors like obesity, hypertension, and hyperlipidemia, represents a global health crisis that significantly impacts life expectancy, quality of life, and healthcare costs.To address this challenge, the AccessCMD project aims to create a comprehensive registry with recall capacity for CMD and multimorbidity.This initiative leverages electronic health records (EHR) to identify potential participants, enhancing our understanding of CMD through robust data collection and participant engagement strategies.

View full poster

Related articles
Continue reading
All news
Company News
Partners
July 31, 2026
Landmark study launches across the US and UK to detect Parkinson's disease before symptoms appear
uMed in partnership with Queen Mary University of London initiated a study to uncover how Parkinson’s develops years before diagnosis, generating one of the richest datasets of its kind - with potential to advance early detection of other brain diseases
Read more
Company News
Partners
May 11, 2026
uMed and Cera partner to bring clinical research to the point of care.
Expanding trial recruitment to a long-underserved 65+ cohort.
Read more
Company News
Partners
October 30, 2025
Partnering with WellSky to expand the reach of real-world data
Read more
Book a complimentary demonstration.
For a clear picture of how uMed could work for you, book a free session with our team.

hello@umed.io
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.